Name: Actuate Therapeutics, Inc. (ACTU) Balance Sheet
Creator: FinSpry

Actuate Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Actuate Therapeutics, Inc. (ACTU) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	8.64	2.96	20.45
Cash & Short-Term Investments	8.64	2.96	20.45
Accounts Receivable	0.00	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.57	0.04	0.03
Total Current Assets	9.21	3.00	20.48
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00
Other Non-Current Assets	0.11	0.00	0.00
Total Non-Current Assets	0.11	0.00	0.00
Total Assets	9.32	3.00	20.48
Current Liabilities
Accounts Payable	1.92	3.42	2.13
Accrued Liabilities	6.88	3.50	2.21
Other Current Liabilities	6.88	0.00	0.00
Total Current Liabilities	8.80	6.92	4.34
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00
Other Non-Current Liabilities	0.41	0.54	0.49
Total Non-Current Liabilities	0.41	95.70	91.44
Total Liabilities	9.21	7.46	4.84
Stockholders' Equity
Common Stock	0.00	0.00	0.00
Retained Earnings	-132.38	-105.09	-80.35
Additional Paid-in Capital	132.48	5.47	5.04
Shares Outstanding	19.53	19.11	19.11
Total Stockholders' Equity	0.10	-4.46	15.65
Total Liabilities & Equity	9.32	3.00	20.48